News

  • Jun
    17
    2020

    The Pulmonary Fibrosis Foundation’s Commitment to Equality

    The Pulmonary Fibrosis Foundation is committed to its mission to drive research and act as the trusted resource for individuals afflicted with pulmonary fibrosis. We exist to serve people of every race and background, and we know that the suffering resulting from PF is often accompanied by other painful hardships borne by patients and their loved ones.
    Read Full Article The Pulmonary Fibrosis Foundation’s Commitment to Equality
  • Jun
    10
    2020

    Pulmonary Fibrosis Foundation Expands Medical Team

    The Pulmonary Fibrosis Foundation (PFF) announced the appointment of three highly respected pulmonologists as senior members of its medical team. The new team members are: Dr. Amy Hajari Case of Piedmont Healthcare (Atlanta); Dr. Sonye Danoff of the Johns Hopkins University School of Medicine (Baltimore); and Dr. Joyce Lee of the University of Colorado Anschutz Medical Campus (Aurora). They will bring a combined 40-plus years of expertise in treating individuals with interstitial lung disease (ILD).
    Read Full Article Pulmonary Fibrosis Foundation Expands Medical Team
  • Apr
    13
    2020

    The PFF's Letter to CMS

    Pulmonary fibrosis patients are at high-risk of complications related to COVID-19 and need protections that reduce their chance for exposure to the virus. At the same time, many pulmonary fibrosis patients rely on pulmonary rehabilitation (PR) services. PR has been shown to improve many PF patients’ exercise capacity and health-related quality of life. Because there are limited treatment options for PF, pulmonary rehabilitation is all the more essential for helping to maintain PF patients’ health.
    Read Full Article The PFF's Letter to CMS
  • Apr
    03
    2020

    In-Person Testing and Signature Requirements Waived for Home Oxygen Needs

    CMS guidelines for supplemental oxygen adjusted to protect patients during COVID-19 crisis
    Read Full Article In-Person Testing and Signature Requirements Waived for Home Oxygen Needs
  • Mar
    16
    2020

    COVID-19 FAQs

    To limit or prevent the spread of COVID-19, several recommendations have been suggested by the Centers for Disease Control (CDC). Read our FAQ for pulmonary fibrosis patients.
    Read Full Article COVID-19 FAQs
  • Mar
    16
    2020

    PFF COVID-19 Guidance Statement

    The Pulmonary Fibrosis Foundation medical team is actively monitoring the evolving outbreak of the COVID-19 coronavirus to evaluate the potential health implications for the pulmonary fibrosis (PF) community in the USA. Read our Guidance Statement here.
    Read Full Article PFF COVID-19 Guidance Statement